Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Lineage Cell Therapeutics, Inc. shareholders
As of Sep 30, 2026, 138 institutions reported holding Lineage Cell Therapeutics, Inc., 46.3% of its shares. Largest: Broadwood Capital Inc, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Lineage Cell Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 49.6M | 19.6% | no change | Nov 13, 2026 |
| BlackRock | 13.9M | 5.5% | +684K | Nov 13, 2026 |
| Vanguard | 11.9M | 4.7% | −194K | Nov 16, 2026 |
| Defender Capital, LLC. | 6.65M | 2.6% | +50,000 | Oct 1, 2026 |
| Geode Capital | 5.34M | 2.1% | +39,897 | Nov 6, 2026 |
| Raffles Associates LP | 5.2M | 2.1% | no change | Nov 16, 2026 |
| Fifth Third Bancorp | 4.9M | 1.9% | +300K | Nov 5, 2026 |
| State Street | 2.93M | 1.2% | +612K | Nov 12, 2026 |
| Millennium | 2.63M | 1.0% | −390K | Nov 16, 2026 |
| Northern Trust | 1.66M | 0.66% | +1,004 | Nov 16, 2026 |